Related Experiment Video

Updated: Aug 30, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Adriamycin (ADM) induced apoptosis in transitional cell cancer (TCC) cell lines accompanied by p21 WAF1/CIP1

V N Bilim1, Y Tomita, T Kawasaki

  • 1Department of Urology, Niigata University School of Medicine, Japan. vbilim@med.niigata-u.ac.jp

Apoptosis : an International Journal on Programmed Cell Death
|January 1, 1997
PubMed

Insights

Adriamycin (ADM) triggers apoptosis in bladder cancer cells by affecting p53, p21, Bcl-2, and Bax proteins. Cancer cell susceptibility to ADM-induced apoptosis depends on these key protein levels.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Genotoxic stimuli, such as anticancer drugs, can induce apoptosis (programmed cell death) in cancer cells.
  • The p53 tumor suppressor protein and its downstream target p21WAF1/CIP1 play crucial roles in mediating this apoptotic response.
  • Members of the Bcl-2 protein family, including Bcl-2 and Bax, are critical regulators of apoptosis, either by modifying the p53 pathway or being directly regulated by p53.

Purpose of the Study:

  • To investigate the role of p53, p21WAF1/CIP1, and Bcl-2 family proteins (Bcl-2, Bax) in Adriamycin (ADM)-induced apoptosis in human bladder cancer cell lines.
  • To determine how the status of these proteins influences the sensitivity of bladder cancer cells to ADM treatment.

Main Methods:

  • Treatment of four human bladder cancer cell lines with Adriamycin (ADM).
  • Assessment of dose-dependent cell death and characteristic morphologic features of apoptosis.
  • Analysis of the expression levels and status of p53, p21WAF1/CIP1, Bcl-2, and Bax proteins.

Main Results:

  • ADM treatment induced dose-dependent apoptosis in bladder cancer cells.
  • The RT4 cell line, characterized by wild-type (wt) p53, a low Bcl-2 to Bax ratio, and induction of p21WAF1/CIP1 following ADM exposure, exhibited the highest sensitivity to ADM-induced apoptosis.
  • Variations in p53, p21WAF1/CIP1, Bcl-2, and Bax expression correlated with differential sensitivity to ADM.

Conclusions:

  • The expression status of p53, p21WAF1/CIP1, Bcl-2, and Bax are significant determinants of bladder cancer cell susceptibility to Adriamycin-induced apoptosis.
  • Understanding these molecular markers could aid in predicting treatment response and developing targeted therapeutic strategies for bladder cancer.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...